This laboratory study purified high-molecular-weight beta-1,3/1,6-glucans secreted by two Diaporthe endophytes. Structural analysis identified a beta-1,3-linked backbone with glucose branches at the 1,6 position. The preparations reduced metabolic viability in cultured MCF-7 breast-cancer and HepG2-C3A liver-cancer cells under some test conditions. The work concerns Diaporthe glucans, not Aureobasidium beta-glucan, and measures short-term cell responses. It does not demonstrate tumor treatment, immune stimulation, antioxidant effects, or safety in animals or humans.
Two Diaporthe beta-glucans were purified, structurally characterized, and tested in two cancer-cell lines.
Reduced cell viability in vitro does not establish anticancer treatment efficacy, and the glucans were not from Aureobasidium.
AI-generated summary for accessibility. Always refer to the original paper.
Orlandelli R., Corradi da Silva M., Vasconcelos A., Magalhaes A., Telles M., Filho J., Pamphile J.. β-(1 → 3,1 → 6)-d-glucans produced by Diaporthe sp. endophytes: Purification, chemical characterization and antiproliferative activity against MCF-7 and HepG2-C3A cells. International Journal of Biological Macromolecules. 2017. DOI: 10.1016/j.ijbiomac.2016.10.048.
For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.